Pfizer and BioNTech SE Submit Data on Covid Vaccine for Kids 5-11 to FDA; Emergency Use Authorization Could Come By Halloween
The pharmaceutical companies are confident they're one step closer to making vaccination an option for millions of younger children.
Millions of anxious parents are one formality closer to having the option of vaccinating their kids against Covid-19. This morning, Pfizer and BioNTech SE announced that they have submitted data from comprehensive trial results of their mRNA vaccine on children ages 5-11 to the U.S. Food and Drug Administration (FDA). The statement referred to last week's disclosure that "the safety profile and immunogenicity data in children aged 5 to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose.”
In other words, after a three-phase trial conducted with thousands of participants from diverse backgrounds, the companies are confident that a modified dosage of their product is safe and efficacious for kids in kindergarten and up.
An important note is that, although the FDA intends to immediately start poring over the data, Pfizer and BioNTech have not yet applied for Emergency Use Authorization from the agency, the final procedural step before vaccines can be administered those in question. But per their newest statement, that "is expected to follow in the coming weeks."
And as Dr. Anthony Fauci has mentioned in recent days, that could mean parents who choose to vaccinate their elementary-aged children might be able to do just that by late October.
As of this writing, nearly 687,000 Americans have died from Covid-19 infection. Between June 16 and August 14, child hospitalizations due to Covid infections rose nearly tenfold over the prior six-week period.
Entrepreneur Editors' Picks
-
Crypto Doesn't Have to Be Serious. Just Ask This Comedian Who Organized a Conference About Failure in the Industry.
-
Want to Succeed? Turn Your Fixed Mindset Into a Growth Mindset.
-
Google's CEO Is Asking Employees 3 Simple Questions to Boost Productivity
-
'Greatest Storyteller Wins.' Katy Perry on the Surprising Link Between Pop Stardom and Entrepreneurship.
-
How to Unleash Your Creativity and Transform Your Marketing Strategy
-
The 5 Personalities You Meet in a Coworking Space
-
'Man's Best Friend' — and Investment: The Thriving Industry of Pet-Related Franchising